Pharmacokinetics in Mice of Four Oligomer-Conjugated Polymers for Amplification Targeting

Cancer Biotherapy and Radiopharmaceuticals

Volumn 18, Issue 6, 2003, Pages 941-947

  He, Jiang ^a   Liu, Guozheng ^a   Zhang, Surong ^a   Rusckowski, Mary ^a   Hnatowich, Donald J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

ORF; Pharmacokinetics; Phosphorodiamidate morpholino; Polymer conjugates

Indexed keywords

MORPHOLINE DERIVATIVE; MORPHOLINOPHOSPHORODIAMIDATE; OLIGOMER; POLYMER; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOSCINTIGRAPHY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; OLIGOMERIZATION; POLYMERIZATION; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0347569577     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497803322702905     Document Type: Article

References (17)

1. Goodwin DA, Meares CF, McCall MJ, et al. Pretargeted immunoscintigraphy of murine tumors with indium-111 labeled bifunctional haptens. J Nucl Med 1988;29:266.
2. Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987;28:1294.
3. Bos ES, Kuijpers WH, Meesters-Winters M, et al. In vitro evaluation of DNA-DNA hybridization as a two-step approach in radioimmunotherapy of cancer. Cancer Res 1994;54:3479.
4. Chang CH, Sharkey RM, Rossi EA, et al. Molecular advances in pretargeting radioimmunotherapy with bispecific antibodies. Mol Cancer Ther 2002;1:553.
5. Rusckowski M, Qu T, Chang F, Hnatowich DJ. Pretargeting using peptide nucleic acid. Cancer 1997;80(suppl.):2699.
6. Wang Y, Chang F, Zhang Y, et al. Pretargeting with amplification using polymeric peptide nucleic acid. Bioconjugate Chem 2002;12:807.
7. Mang'era K, Liu G, Wang Y, et al. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications. J Nucl Med 2001;28:1682.
8. 99mTc-morpholinos in mice. Quart J Nucl Med 2002;46:233.
9. Liu G, Mang'era K, Liu N, et al. Tumor pretargeting in mice using 99mTc labeled morpholinos, a DNA analogue. J Nucl Med 2002;43:384.
10. Liu G, He J, Zhang S, et al. Chain length and base sequence of 99mTc labeled morpholinos influence only kidney levels in mice and only due to cytosines. Anti-sense Nucleic Acid Drug Dev 2002;12:393.
11. 3 for technetium-99m labeling of DNA. Nucl Med Biol 1997;24:425.
12. Ward TC. Molecular weight and molecular weight distributions in synthetic polymers. J Chem Edu 1981;58:867.
13. Suzuki H, Nakai D, Seita T, Sugiyama Y. Design of a drug delivery system for targeting based on pharmacokinetic consideration. Adv Drug Deliv Rev 1996;19:355.
14. Hnatowich DJ. Antisense and nuclear medicine. Where are we now? Cancer Biother Radiopharm 2000;15:447.
15. Rogers YH, Jiang-Baucom P, Huang ZJ, et al. Immobilization of oligonucleotides onto a glass support via disulfide bonds: A method for preparation of DNA microarray. Analytical Biochemistry 1999;266:23.
16. Guo Z, Guilfoyle RA, Thiel AJ, et al. Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports. Nucleic Acids Res 1994;22:5456.
17. Kassis AI, Jones PL, Matalka KZ, Adelstein SJ. Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or strepavidin. J Nucl Med 1996;37:343.